NCT06640777: Efficacy and Safety of LEAF-4L6715 for Acute Respiratory Distress Syndrome
- State
- Not started
- Phase
- Phase 3
- People
- 310 planned
- Started
- 1 Nov 2024
- Primary completion
- 9 Nov 2026
- Arms
- LEAF-4L6715 (Liposomal Transcrocetin) + Supportive Care
- Results
- None posted
- 15 Oct 2024: Trial registered